ema glp-1 vision loss recommendation november 2025 Novel drugs approved by the EMA, the FDA and the MHRA in 2024: A year in review - Topouzis - - British Journal of Pharmacology Everything you need to know

Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma

Medical history: Your doctor may ask about your personal or family medical history, searching for patterns that point to mold toxicity

High doses of L-Carnitine may increase the risk of seizures in people with epilepsy

Breathing technology improves freeze while minimising bruising from the suction

From soft tissues to bones and nerves, BPC 157 tackles damage at the core

Although it shows good efficacy, fear of needles contributes to poor adherence, leading to inadequate blood sugar control and recovery hindrance